Related Experiment Video
Updated: Aug 10, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
[A clinical study of Kaposi's sarcoma associated with the acquired immunodeficiency syndrome]
V Pintado García1, M López-Dupla, E Valencia Ortega
1Servicio de Medicina Interna, Hospital La Paz, Universidad Autónoma, Madrid.
Abstract:
We have retrospectively studied 35 cases of Kaposi's sarcoma in 460 patients with AIDS (incidence of 7.6%) during a period of 10 years. All of them were males, with a mean age of 38 years. 88% of the cases belonged to the homosexual risk group. The tumor was the diagnostic criteria of AIDS in 25 patients. At the moment of the diagnosis, 4 patients were at stage I, 23 at stage II, 1 at stage III and 7 at stage IV, according to the Mitsuyasu's classification; 7 patients had systemic symptoms. The tumor was localized at the skin (34 cases), mucosa (16), digestive tract (7), lung (6) and ganglion (4). The immunological study revealed lymphopenia in 74% of patients, reduction of T4 lymphocytes ( < 0.5 x 10(9)/L) in 93% and inverted T4/T8 ratio in 96%. Sixteen patients received antitumoral treatment (8 with chemotherapy, 7 with interferon and 5 with radiotherapy). The response was stabilization of lesions in 8 cases, partial remission in 2 and progression in 3; in other 3 cases, such response was not assessed. The mortality was 48% and the average survival, 13 months. Opportunistic infections were the cause of death in most patients. Our results confirm the clinical and evolutive characteristics of the Kaposi's sarcoma associated to AIDS; disseminated cutaneous affectation with frequent visceral affectation, poor response to treatment and low survival associated to the presence of opportunistic infections. The lower incidence of tumor observed in our study is related to the different distribution of the risk groups for HIV in our country.
Insights
Kaposi's sarcoma in patients with acquired immunodeficiency syndrome (AIDS) often presents as widespread skin lesions and frequently affects internal organs. Survival is poor, with opportunistic infections being the primary cause of death.
Area of Science:
- Oncology
- Infectious Diseases
- Immunology
Context:
- Retrospective study of 35 Kaposi's sarcoma (KS) cases among 460 patients with acquired immunodeficiency syndrome (AIDS) over 10 years.
- KS was the initial diagnostic criterion for AIDS in 25 patients.
- Predominant affected demographic: males, mean age 38, 88% from homosexual risk group.
Purpose:
- To analyze the clinical and evolutive characteristics of Kaposi's sarcoma in patients with AIDS.
- To evaluate the incidence, staging, localization, immunological status, treatment response, and survival rates of KS in this population.
Summary:
- High incidence of KS (7.6%) in AIDS patients, primarily affecting skin, mucosa, and visceral organs (digestive tract, lung, lymph nodes).
- Immunological findings include significant lymphopenia (74%), reduced T4 lymphocytes (93%), and inverted T4/T8 ratio (96%).
- Treatment response to chemotherapy, interferon, or radiotherapy was limited, with a 48% mortality rate and a median survival of 13 months, often due to opportunistic infections.
Impact:
- Confirms the aggressive nature of AIDS-associated Kaposi's sarcoma, characterized by disseminated lesions, visceral involvement, and poor treatment outcomes.
- Highlights the critical role of opportunistic infections in mortality.
- Suggests that observed lower incidence may be linked to variations in HIV risk group distribution.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cryptococcal Meningitis
Amebiasis

